Disclosed are phenylketone carboxylate compounds of formula I where the substituents are as defined herein such as (RS)-2[4-octanoylphenoxy]decanoate. Also disclosed are their methods of synthesis and the use of such compounds in the treatment of blood disorders, inflammation-related diseases, renal disorders and fibrosis related organ dysfunction.